About Dr. Narender Kumar Thota
Dr. Narender Kumar Thota is a well-known Hemato-Oncologist and Bone Marrow Transplant Specialist with over two decades of expertise. He specialises in the diagnosis and management of complex blood cancers such as leukaemia, lymphoma, and multiple myeloma. He is regarded as an expert in both autologous and allogeneic stem cell transplants, including high-risk adult and pediatric cases.
Why Choose Dr. Narender Kumar Thota?
- Extensive Oncology Expertise: With over 24 years of overall medical experience, Dr. Thota is skilled in diagnosing and managing high-risk haematological malignancies like acute leukaemias and multiple myeloma.
- Advanced Transplant Specialist: He is proficient in complex autologous and allogeneic bone marrow and stem cell transplants, significantly improving survival outcomes for patients with severe blood disorders.
- Evidence-Based Care: He utilises modern, cutting-edge therapies, including targeted chemotherapy, precision medicine, and immunotherapy, to ensure highly personalised and effective treatment plans.
- Significant Clinical Impact: He played an important role in developing the stem cell transplant program at KIMS and continually advances regional oncology services through his rigorous academic research, publications, and international training.
OPD Schedule Of Dr. Narender Kumar Thota
KIMS Hospital, Secunderabad

Location
MBBS, Kakatiya Medical College, Warangal, India(2002)
MD, Gandhi Medical College, Hyderabad, India(2008)
DM, Nizam's Institute of Medical Sciences (NIMS), Hyderabad, India(2012)
Fellowship, Fellowship, Case Western Reserve University / Los Angeles, California, USA(2013)
Fellowship, Fellowship, City of Hope National Medical Center, Los Angeles, California, USA(2013)
- 2nd Prize: "Adult Promyelocytic Leukaemia, Retrospective Analysis" presentation at a national forum
- Best Poster Recognition: Judged as presenting one of the best posters from India for the American Society of Clinical Oncology (ASCO), Chicago, USA (June 2011)
- Travel Grant Award: Selected for a travel grant for the International Society of Paediatric Oncology (SIOP), Boston, USA (2010)
Memberships
- Indian Medical Association (IMA)
- Indian Society of Medical and Paediatric Oncology (ISMPO)
- American Society of Clinical Oncology (ASCO)
- European Society of Medical Oncology (ESMO)
- Indian Society of Haematology and Blood Transfusion (ISHBT)
- European Haematology Association (EHA)
- American Society of Haematology (ASH)
Papers Published
- Efficacy, safety and cost effectiveness of reduced-dose olanzapine versus aprepitant as a part of triple-antiemetic therapy in the prevention of chemotherapy-induced nausea and vomiting – Journal of Clinical Oncology (ASCO), 2022.
+ Read More- Show Less
- A retrospective study on pemetrexed-induced nephrotoxicity in non-small cell lung carcinoma patients – International Journal of Basic & Clinical Pharmacology, 2021.
- Primary Ewing's Sarcoma of the Cranium - Case Series and Review of Literature – Journal of Cancer Research and Therapeutics, 2014.
- Diagnostic Dilemma Of Cardiac Synovial Sarcoma - Primary Or Secondary – Journal of Indian College of Cardiology, 2013.
- Management strategies of epistaxis with different etiologies – International Journal of Otorhinolaryngology and Head and Neck Surgery.
- Bortezomib in newly diagnosed patients with Multiple Myeloma: a retrospective analysis from a tertiary care centre in India – Indian Journal of Cancer.
- Imatinib mesylate as first-line therapy in patients with chronic myeloid leukaemia in accelerated phase and blastic crisis: A retrospective analysis – Indian Journal of Cancer.
Send Your Enquiry
Fill in your details and our medical experts will contact you within 24 hours.
Want to consult the doctor?
Don't Ignore Your Health!

